R&D-Driven and AI-Powered Biopharmaceutical Company | Sanofi
1 day ago · Sanofi is a research & development-driven, AI-powered healthcare biopharmaceutical company committed to improving lives through innovative medicines & vaccines.
Sanofi Pharmaceuticals - Healthcare Innovations | Sanofi USA
Discover how Sanofi, a global pharmaceutical company, is shaping healthcare in the US with innovative solutions and treatments.
Sanofi - Wikipedia
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris. The corporation was established in 1973 and merged with Synthélabo in 1999 to form …
Sanofi to Buy Dynavax for $2.2 Billion to Add Shingles ...
Dec 24, 2025 · Sanofi agreed to buy Dynavax Technologies Corp. for about $2.2 billion, as it seeks to expand a vaccines business currently anchored by its flu shot franchise.
Sanofi bolsters adult vaccine roster with $2.2B Dynavax purchase
Dec 29, 2025 · Acquisitive Sanofi keeps deals coming, laying out $2.2B for hepatitis vaccine maker Dynavax By Fraiser Kansteiner Dec 29, 2025 10:24am Sanofi Dynavax Technologies …
Sanofi's 2nd autoimmune pact with AI biotech could reach $2.5B
1 day ago · Sanofi has returned to U.S. artificial intelligence research biotech Earendil Labs for another significant autoimmune and immunology development pact. The latest agreement …
Sanofi to Buy Vaccine Maker Dynavax in $2.2 Billion Deal
Dec 24, 2025 · Sanofi agreed to buy vaccine specialist Dynavax Technologies in a $2.2 billion cash deal, turning to dealmaking in a bid to move past pipeline setbacks. The French …